Meda set to acquire Rottapharm Madaus

31 July 2014 - Deborah Wilkes

Archived

Sweden's Meda is set to strengthen its presence in the consumer healthcare market by acquiring privately-owned Italian company Rottapharm Madaus in a cash and shares deal worth SEK21.2 billion (US$3.08 billion).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: